首页 › 卵巢癌 › 印第安纳州 › Fort Wayne
Fort Wayne IN 卵巢癌临床试验
8项针对 卵巢癌的研究正在 Fort Wayne及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Parkview Research Center /ID# 274338, Fort Wayne
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
招募中3 期
- Parkview Research Center at Parkview Regional Medical Center ( Site 0055), Fort Wayne
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中2 期
- Parkview Research Center, Fort Wayne
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
招募中3 期
- Parkview Research Center at Parkview Regional Medical Center ( Site 0003), Fort Wayne
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Parkview Regional Medical Center, Fort Wayne
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Parkview Research Center, Fort Wayne
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
招募中1/2 期
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
其他城市的 卵巢癌试验
- Houston, TX89 项研究
- New York City, NY69 项研究
- Boston, MA61 项研究
- Los Angeles, CA50 项研究
- Nashville, TN49 项研究
- Arlington, VA46 项研究
- Philadelphia, PA44 项研究
- Columbus, OH39 项研究
- St. Louis, MO38 项研究
- Chicago, IL36 项研究
- San Antonio, TX31 项研究
- Cleveland, OH30 项研究
Fort Wayne的其他研究
- 非小细胞肺癌17 项研究
- 癌症（所有类型）7 项研究
- 慢性淋巴细胞白血病7 项研究
- 乳腺癌7 项研究
- 肺癌6 项研究
- 转移性癌症6 项研究
- 子宫内膜癌5 项研究
- 黑色素瘤4 项研究
- 头颈鳞状细胞癌4 项研究
- 三阴性乳腺癌4 项研究
- 结直肠癌4 项研究
- 多发性骨髓瘤4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。